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Abstract
Background: Aeromonas species can cause a wide spectrum of illnesses varying from intestinal to extra intestinal
and vary in their susceptibility to different antibiotics. The current study was undertaken to characterize the third
generation cephalosporin-resistant strains of Aeromonas spp. which were isolated from stool specimens.
Methods: Out of a total of 2780 stool samples, 29 Aeromonas spp. were identified, out of which, 9 were resistant
to ceftriaxone by the Kirby-Bauer antibiotic testing method. These strains were subjected to minimum inhibitory
concentration (MIC) determination by agar dilution for ceftriaxone. Phenotypic and genotypic testing of AmpC
beta-lactamase and extended spectrum beta-lactamase (ESBL) were performed. Gene transfer was carried out to
demonstrate transmissibility of these genetic elements by conjugation experiments.
Results: Out of the 29 strains, 9 showed MIC of ≥4 μg/ml. Seven out of 9 showed presence of blaCTX-M, while 2
more strains showed the presence of inducible AmpC beta-lactamase and presence of MOX gene. Gene transfer
experiments showed that these elements were transmissible to recipient (Escherichia coli J53 strain) in the presence
of ceftriaxone.
Conclusions: Dissemination of these resistance determinants like plasmids is pivotal in the spread of these
resistance genes into the aquatic environment into organisms like Aeromonas. This may further limit the future
use of antibiotics for the treatment of diarrhoeal diseases. Hence, detection and antibiotic susceptibility testing
of Aeromonas spp. should be performed when isolated from stool samples.
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Background
The family Aeromonadaceae contains the members of
the genus Aeromonas which are Gram-negative rods,
facultative anaerobes and oxidase-positive. They are ha-
bitants of a wide range of aquatic environment like fresh,
marine and estuarine water, as well as sewage where the
bacterial ecosystem co-exists as well as are natural path-
ogens of aquatic life forms like fishes, etc. [1].
A number of Aeromonas species are described, but the
taxonomy of the genus Aeromonas is confusing because
of the lack of congruity between the phenotypic and
genotypic characters. Now, several DNA hybridization
methods are available based on which Aeromonas species
are classified [1, 2]. Important Aeromonas species which
are pathogenic for humans include Aeromonas hydrophila,
Aeromonas sobria, Aeromonas trota, and Aeromonas
caviae [1, 3, 4].
Today, Aeromonas species are considered not only
pathogenic to cold-blooded animals and fishes, some of
the species are pathogenic to animals and humans also,
both immunocompetent and immunocompromised. The
spectrum of infections caused by Aeromonas species varies
from various intestinal manifestations to extra intestinal
complications namely gastrointestinal tract syndromes,
wound and soft tissue infections, urinary tract infections
and rarely septicaemia [1, 2].* Correspondence: drjharna@gmail.com
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The role of Aeromonas as a gastrointestinal pathogen
has been controversial as 1-4 % of asymptomatic individ-
uals are known to harbour them in their gut. However,
Aeromonas-associated acute bacterial gastroenteritis has
been reported from across the world. The gastrointes-
tinal manifestations can vary from an acute gastroenter-
itis presenting with an acute watery diarrhoea, choleraic
illness to a more severe form accompanied by dysentery
rarely leading to hemolytic uremic syndrome [1–4].
Susceptibility to the antibiotics varies according to the
geographical area and the species of Aeromonas tested.
Most of the isolates are generally susceptible to tetracy-
clines and quinolones though development of increasing
resistance to third generation cephalosporins due to the
production of beta-lactamases and extended spectrum
beta-lactamases (ESBLs) has been noted in the recent
years [2, 3, 5]. The current study was undertaken to
characterize the third generation cephalosporin-resistant
strains of Aeromonas spp. which were isolated from
stool specimens.
Methods
The present study was a descriptive study conducted in
a tertiary care centre in South India. All consecutive
non-duplicate stool isolates of Aeromonas spp. resistant/
intermediate to ceftriaxone by Kirby-Bauer disc diffusion
method during a study period of 3 years from January
2010 to December 2012 were included in the study. These
isolates were characterized phenotypically and genotypi-
cally for determining ceftriaxone resistance mechanisms.
Bacterial isolates
A total of 2780 stool samples were processed, out of
which, 29 (1.04 %) Aeromonas spp. were identified. Total
samples positive for other pathogens were Shigella (6.1 %),
non-typhoidal salmonellae (1.29 %) and Vibrio cholerae
(7 %) among the bacterial causes of diarrhoea, during the
study period of 2 years using the cultural characteristics
and standard biochemical reactions, followed by confirm-
ation with respective antisera wherever applicable [6, 7].
In these 29 patients, no other pathogen was isolated, and
Aeromonas spp. were the single pathogen isolated.
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing of all the isolates was
performed on Mueller-Hinton agar plates by standard
Kirby-Bauer disc diffusion method as per the standard
procedure mentioned in Clinical Laboratory Standards
Institute guidelines for Aeromonas spp. [8]. The isolates
were tested to the following panel of antibiotics including
the beta-lactam and the non-beta lactam group of anti-
biotics namely ceftriaxone (30 μg), ciprofloxacin (5 μg),
tetracycline (30 μg), cotrimoxazole (1.25/23.75 μg) and
chloramphenicol (30 μg). All the isolates resistant to
ceftriaxone were further subjected to minimum inhibitory
concentration (MIC) determination for ceftriaxone and
characterized phenotypically and genotypically for other
cephalosporin resistance mechanisms like AmpCBL (beta-
lactamase) production. Since the current updated CLSI
guidelines do not necessarily recommend performing
ESBL testing routinely with the modified zone diameters
for ceftriaxone, we therefore did not perform any further
phenotypic tests for the ESBL production.
Determination of MIC—MIC of a particular strain
intermediate/resistant to ceftriaxone by routine disc diffu-
sion method was determined using ceftriaxone agar dilu-
tion method using ceftriaxone pure powder (Himedia,
Mumbai, India). MIC was performed on Mueller-Hinton
agar containing doubling dilutions of ceftriaxone ranging
from 0.5 to 8 μg/ml. Plates were incubated at 37 °C for
18 h. MIC value of ≤1 μg/ml is considered to be sensitive,
2 μg/ml to be intermediate and ≥4 μg/ml to be resistant to
ceftriaxone [6–8].
Detection and identification of various beta-lactamase
genes—All the Aeromonas species resistant to ceftriaxone
by disc diffusion method and further by agar dilution
method was further subjected to PCR for identification of
various beta-lactamases viz—ESBLs and AmpCBLs.
Preparation of template DNA—DNA was extracted
from the isolates by using the boiling method as described
previously [9].
ESBL gene detection—Most of the ESBLs genes are
variants of blaTEM and blaSHV, but blaCTX-M are also
increasingly becoming important. The various genes tar-
geted for detection of ESBLs in the present study were
blaTEM,blaSHV and blaCTX-M. A duplex PCR for bla-
TEM and blaSHV was done using the primer sequence
and the cycling conditions of Jemima et.al. [9], and a
simple PCR was performed for the detection of blaCTX-
M-sing the primer sequence and the cycling conditions
as mentioned previously [10]. Amplicons obtained were
analyzed by gel electrophoresis using 2 % agarose. Gels
were stained by ethidium bromide and visualized by UV
transillumination.
Detection of AmpCBL production—The various AmpCBL
genes targeted were MOX, CITM, FOX, DHAM, ACCM
and EBCM [11]. A multiplex PCR was performed for
the detection of these genes using the primer sequence
and cycling conditions as described earlier [12]. Sequen-
cing of these genes was conducted by Macrogen Inc.
(Seoul, South Korea). We used the BLASTN program
(www.ncbi.nlm.nih.gov/BLAST) for database searching.
Transfer of resistance genes—A conjugation experi-
ment for the transferability of the resistance genes was
conducted using broth mating experiment with sodium
azide resistant E. coli strain J53 as the recipient strain as
per Lee et al. [13]. Equal volumes (4 ml) of cultures of
ceftriaxone-resistant Aeromonas strain and E. coli strain
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J53 (each at 109 cfu/ml) grown in brain-heart infusion
broth were mixed. Mixtures were incubated at 37 °C for
18 h. Transconjugants were selected on MacConkey agar
with sodium azide (150 mg/l) to inhibit the donor strain
and with ceftriaxone (1 mg/l) to inhibit the growth of
the recipient strain.
Confirmation of transconjugants by PCR amplifica-
tion—Three to five colonies of the transconjugants were
selected to confirm the plasmid transfer of resistance
genes. Colonies were picked up from the MacConkey
plates containing ceftriaxone (1 mg/l) and DNA extracted
from the colonies using boiling lysis method as described
above. The supernatant was taken as the template for PCR
amplification for detection of AmpCBL and ESBL genes.
Results
A total of 9 Aeromonas species out of 29 strains were
found resistant to ceftriaxone by Kirby-Bauer disc diffu-
sion method. All these 9 strains showed MIC of ≥ 4 μg/
ml which indicated that they were resistant to ceftriax-
one. Seven out of 9 were ESBL producers and showed
the presence of blaCTX-M, while 2 more strains showed
the presence of inducible AmpCBL. None of these 9 iso-
lates showed the presence of blaTEM or blaSHV. On se-
quencing these amplicons of blaCTX-M, we found that
they had 99 % identity with E. coli strain blaCTX-M-15
(Genome accession no: FJ997868.1).
Two of the 9 strains showed the presence of AmpCBL
gene at 490 bp position which corresponded to the MOX
gene. On sequencing, it was found to match 99 % with
Aeromonas punctate strain blaMOX-sequence (Genome
accession no: FJ262599.1). Co-production of AmpCBL
and ESBL was not found in any of our study isolates.
The results of the conjugation experiments followed
by the PCR amplification of the transconjugants showed
that all 9 strains (7 ESBL producers and 2 AmpCBL pro-
ducers) were able to transfer their resistance genes to the
E. coli J53 strain. These tranconjugants were subjected to
PCRs for the detection of ESBL and AmpCBL genes,
which confirmed the transfer in the 9 strains.
Discussion
Although the reports of ESBLs associated with Aeromo-
nas spp. are rare when compared to the other members
of Enterobacteriaceae family, the most common type of
CTX-M described in India is CTX-M-15. Though there
are reports on ceftriaxone resistance in Aeromonas from
India, molecular characterization studies on ceftriaxone
resistance from stool samples are currently not available
from India. In our hospital, normally for all watery diar-
rhoea mainly, rehydration therapy is prescribed, and in
case of invasive diarrhoea/dysentery, the antibiotic pre-
scribed usually is cefixime. A lot of ESBLs including
TEM-24, TEM-63 and SHV-12 have also been described
in Aeromonas spp. [14–17].
Previous studies unquestionably established the role
(>85 % of isolates) of many Aeromonas spp. such as
the A. hydrophila, A. caviae and A. veronii bv. sobria
in diarrhoea [1, 5].
The Aeromonas have been known to carry many drug
resistance genes. There are several reports citing the
various mechanisms operating. These bacteria can re-
ceive and transfer antibiotic resistance genes to other
Gram-negative bacteria [2].
The concern for drug resistance in these isolates is
well placed as they have originated from the community,
causing diarrhoea in the patients discussed. Routinely,
antibiotic therapy for Aeromonas causing diarrhoea is
not warranted, as it produces self-resolving diarrhoea.
Hence, the finding of antibacterial resistance is of not a
concern as far as diarrhoeal management goes, but since
the same pathogen is associated with extra intestinal
manifestations where the same resistance mechanisms,
operating can spell devastation. Another point of con-
cern is that since these genetic elements are borne on
plasmids, they can be transmitted to other bacteria as
well which may further limit the future use of antibiotics
for the treatment of diarrhoeal diseases due to the latter
bacteria. Our plasmid transfer studies have shown that
these genetic elements can be easily transmitted from
one bacterium to the other each belonging to different
genera. This obviously raises concern knowing the fidelity
and integrity of such genetic elements. The implications
are far extending.
Earlier studies have reflected on the drug resistance
mechanisms in this group. In a study from Kolkata, India,
it was observed that many of the Aeromonas strains were
resistant to furazolidone, quinolones and cephalosporins
[5]. In fact, multiple drug resistance among Aeromonas
spp. have been reported from many parts of the world [16,
18]. In both clinical as well as environmental isolates of
Aeromonas, antibiotic resistance has been observed. In
many studies, an increase in resistance was observed
among strains of Aeromonas isolated from urban effluents
being discharged into rivers [17, 19, 20]. It has been dem-
onstrated in earlier studies that household and industrial
effluents are known to contain high levels of antibiotics
and antibiotic-resistant bacteria of human and animal
origin [19–22].
Based on the findings of the PCR and the sequencing,
the genes are plasmid-borne which is evident from the
plasmid transfer assays. This raises further concern
about such elements operating in the environment.
Aeromonas species producing extended spectrum beta-
lactamases are increasingly being reported. Infections
caused by Aeromonas harbouring ESBL genes and
AmpCBL genes is an important problem in developing
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countries where infections caused by Aeromonas is
common. Organisms expressing AmpCBL is an important
clinical concern since these isolates are usually resistant to
all beta-lactam antibiotics except the fourth generation
cephalosporins like cefepime, cefpirome and the carbapen-
ems [11]. Detection of this resistance mechanism is im-
portant for surveillance, epidemiological studies and
hospital infection control because most of these enzymes
are plasmid-mediated, and this results in the spread of re-
sistance genes among the members of the same as well as
different families. Aeromonas spp. in water habitats act as
mediators between water and commensal gut bacteria es-
pecially members of the Enterobacteriaceae, which further
act as the progenitors of the most commonly encountered
plasmidic-AmpC genes detected in clinical isolates. These
genes have been reported from water bodies and drinking
water biofilms [23–25] so much so that the presence of
genetic elements with sequence homologies to those of
bacterial species such as V. cholerae and Photobacterium
damselae have also been found [26].
Like human gut, water sources act as excellent reser-
voirs where transfer of genetic material including anti-
biotic resistance genes can occur as demonstrated by
earlier workers [11, 24, 26–32]. In strains of Aeromonas
isolated from the several water bodies demonstrated the
presence of AmpCBLs, quinolone resistance determinants
and tetracycline efflux gene, which in turn indicate that
the water bodies are getting polluted with antibiotics. This
might be acting as a selection pressure responsible for
selecting out drug-resistant strains in the environment.
The mechanisms of resistance to third generation
cephalosporins in Aeromonas have been ascribed to the
production of beta-lactamases (ESBLs, AmpCBLs and
carbapenemases), efflux pumps and alterations in the
outer membrane leading to reduced permeability, though
in the present study, we did not look for any of the efflux
pumps or alterations in the outer membrane.
Conclusions
Antibiotic usage in the clinical and non-clinical settings
is important for the emergence of antibiotic-resistant
isolates. ESBL and AmpCBL production are one of the
important resistance mechanisms conferring resistance
to penicillins and cephalosporins. Emergence of these re-
sistance mechanisms in Aeromonas species is important
as these organisms are one of the emerging pathogens in
both immunocompetent and immunocompromised
patients producing a variety of clinical manifestations.
Occurrence of ESBLs and AmpCBLs in Aeromonas
species emphasizes the importance of constant surveillance
of clinical isolates for the prevalence of antibiotic resistance
genes, though routine testing of stool isolates is not recom-
mended. Dissemination of these resistance determinants
due to its location on mobile genetic elements like plasmids
plays an important role in the spread of these resistance
genes in the environment which may further limit the
future use of antibiotics for the treatment of diarrhoeal
diseases.
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